This protocol addresses the management of cutaneous leishmaniasis in a patient who is pregnant. The concurrent condition of pregnancy significantly constrains which treatment approaches can be considered, requiring a tailored strategy distinct from the standard approach.
As none of the systemic treatments are known to be safe during pregnancy, systemic treatment should be withheld until after delivery. Topical treatment may be applied before delivery, depending on clinical assessment.
When systemic therapy must be deferred, simple wound care or selected physical methods may be considered as interim management. The complete structured protocol outlines the specific modalities, their sequencing, and the clinical decision points that guide this approach.
The primary clinical target in this scenario is:
Complete reepithelialization (healing) of the cutaneous lesionDOI: 10.1111/jtm.12089